通过骨髓向的工程外体来抑制USP5,用于骨髓扩散性瘤治疗
Wenjun Wang1,2,3, Yufeng Jiang4, Donglei Zhang1
1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Journal of nanobiotechnology
|July 11, 2025
概括
研究人员确定USP5是骨髓增殖性新生瘤 (MPNs) 的关键驱动因素. 他们开发了向外体,以提供USP5抑制剂,显著减少癌细胞生长,并改善MPN模型中的存活率.
科学领域:
- 生物医学工程 生物医学工程
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 骨髓增殖性瘤 (MPNs) 由于骨髓的复杂微环境和有限的治疗选择,因此存在治疗挑战.
- 目前的疗法往往无法根除恶性克隆,并且受到药物耐药性的阻碍.
研究的目的:
- 确定MPNs的新型治疗点和传递系统.
- 研究USP5在JAK2V617F突变介质干细胞 (MSC) 中的作用.
主要方法:
- 工程外体 (USP5@Exosome-CP) 开发用于增强骨髓 (BM) 向,共同表达CXCR4和P-选择素向.
- 外体被装载了一个USP5抑制剂 (USP5-IN-1),用于持续的药物释放.
- 在MPN小鼠模型中评估了有效性,包括评估MSC增殖,存活率和全身毒性.
主要成果:
- USP5被确定为JAK2V617F突变的MSC中的关键调节者,通过抑制Caspase-3介导的亡来促进增殖.
- USP5@Exosome-CP证明了有效的BM定位和药物输送,显著减少MSC增殖,并在MPN模型中延长存活时间.
- 转录组分析证实USP5敲击激活了亡并抑制了瘤信号,观察到最小的系统毒性.
结论:
- USP5是MPNs的验证治疗标.
- 工程外体平台为MPN治疗提供了一个有前途的基于纳米技术的战略.
- 这种方法为个性化MPN疗法提供了概念验证,提高了疗效,减少了目标外影响.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Bone Marrow Sampling and Transplants
502
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
502
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K


